Aptargroup, Inc.

Industrials
Plastic Products
www.aptar.com

Earnings Score
Moat Score
Safety Score
Final Score

Market Cap $11.30B
PE 34
Debt $1.08B
Cash $325.52M
EV $12.05B
FCF $393.25M

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	$335.56M
EBIT	$460.59M
ROE	13%
ROA	10%
FCF	$393.25M
Equity	$2.55B
Growth Stability	93%
PE	33.67
PEG	4.4
PB	4.42
P/FCF	28.73
P/S	3.16
Price/Cash	0.03
Debt/Equity	0.42
Debt/FCF	2.74
Net Margins	10%
Op. Margins	13%
Earnings CAGR	4%
Sales Growth YoY	2%
Sales Growth QoQ	-0%
Sales CAGR	6%
FCF CAGR	2%
Equity CAGR	9%
Earnings Stability	0.65
Earnings Growth YoY	19%
Earnings Growth QoQ	10%
Earnings CAGR 5Y	8%

Sales CAGR 5Y	6%
FCF CAGR 5Y	-1%
Equity CAGR 5Y	9%
Earnings CAGR 3Y	4%
Sales CAGR 3Y	4%
FCF CAGR 3Y	112%
Equity CAGR 3Y	10%
Market Cap	$11.30B
Revenue	$3.57B
Dividend Yield	1%
Payout Ratio	33%
Assets	$4.63B
Total Debt	$1.08B
Cash	$325.52M
Shares Outstanding	66.18M
EV	12.05B
Earnings Score	52%
Moat Score	91%
Safety Score	92%
Final Score	78%
Working Capital	638.95M
Current Ratio	1.62
Shares Growth 3y	0%
Equity Growth QoQ	6%
Equity Growth YoY	15%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

AptarGroup, Inc., also known as Aptar, is a United States-based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries. The company began as Werner Die & Stamping in Cary, Illinois, in 1946 and later incorporated as AptarGroup in 1992. Aptar originally developed spray valves and pumps for consumer and household products. The company later began producing nasal administration and pulmonary drug delivery devices such as nasal spray systems and metered-dose inhaler valves. Biotech and pharmaceutical companies use Aptar's different Unidose and Bidose devices for the single or two-shot intranasal delivery of different medicines.

SEC Filings

Direct access to Aptargroup, Inc. (ATR) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Aptargroup, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Aptargroup, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 4%

Stability 65%

loading chart...

Aptargroup, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Aptargroup, Inc..

Years

Calculation mode

= $4.5B

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$393M	$401M	$409M	$417M	$425M	$434M	$442M	$451M	$460M	$469M	$478M	$4.8B
DCF		$365M	$338M	$313M	$290M	$269M	$250M	$231M	$215M	$199M	$184M	$1.8B
Value	$4.5B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Net Margins	7%	9%	9%	9%	7%	8%	7%	8%	7%	8%	10%
ROA	-	13%	12%	10%	8%	10%	9%	8%	9%	9%	10%
ROE	-	17%	18%	17%	14%	15%	12%	12%	12%	12%	13%

Net Margins (9.99%)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	4.94	4.78	7.84	12.63	4.48	3.66	21.56	7.67	5.45	2.74
Debt over Equity	0.74	0.75	0.81	1	0.91	0.78	0.64	0.6	0.62	0.62	0.42
Growth Stability	-	-	-	100%	93%	100%	98%	100%	100%	100%	93%

Neutral Debt/FCF ratio (2.74)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Good Debt/Equity ratio (0.42)

The company is not overleveraged and has a good balance between equity and debt.

Good Graham’s Stability (93%)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	-11%	1%	6%	12%	3%	2%	10%	3%	5%	6%
Earnings YoY growth	-	4%	3%	7%	-11%	24%	-12%	14%	-2%	19%	8%
Equity YoY growth	-	4%	2%	12%	8%	10%	18%	7%	4%	12%	9%
FCF YoY growth	-	15%	13%	-15%	-39%	166%	19%	-83%	203%	56%	-1%